Clinic
Chiricahua Community Health Centers, INC
Chiricahua Community Health Centers, INC was paid $19.24M by Medicaid between Jan 2018 and Dec 2024, across 120 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 100% of everything it billed.
33Billing provider infoCHIRICAHUA COMMUNITY HEALTH CENTERS, INC
DOUGLAS, AZ 85607
DOUGLAS, AZ 85607
33aNPI1174820898assigned 02/15/2011
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$19.24M
24GClaims207,889
24DCodes billed120
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Arizona
Rank by total paid#11 of 126
Median peer was paid$1.45M
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MELK, JONATHAN controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,028 | $1.68M | |
| 2019 | 14,376 | $1.51M | |
| 2020 | 14,591 | $2.71M | |
| 2021 | 23,547 | $3.55M | |
| 2022 | 32,395 | $3.06M | |
| 2023 | 50,906 | $3.24M | |
| 2024incomplete | 48,046 | $3.49M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 100% | 64,373 | 48,080 | $19.23M |
| 0001A | <1% | 539 | 535 | $2K | |
| 0002A | <1% | 521 | 517 | $1K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 22,077 | 18,067 | $505.36 |
| 0012A | <1% | 60 | 60 | $480.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,509 | 2,264 | $262.53 |
| 0011A | <1% | 103 | 103 | $240.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,937 | 2,647 | $159.17 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 7,300 | 6,751 | $85.32 |
| 0071A | <1% | 350 | 336 | $46.00 | |
| 92551 | <1% | 5,228 | 4,759 | $41.64 | |
| 99173 | <1% | 5,099 | 4,639 | $34.96 |
108 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,330 | $21.33 |
| 90686 | <1% | 2,541 | $4.94 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,271 | $0.00 |
| 97802 | 0% | 1,213 | $0.00 | |
| 99000 | 0% | 3,364 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 1,318 | $0.00 |
| 3074F | 0% | 3,761 | $0.00 | |
| 99381 | 0% | 456 | $0.00 | |
| 3008F | 0% | 5,461 | $0.00 | |
| 90680 | 0% | 431 | $0.00 | |
| 90651 | 0% | 750 | $0.00 | |
| D1310 | 0% | 1,210 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 2,315 | $0.00 |
| 2001F | 0% | 5,326 | $0.00 | |
| D1330 | 0% | 1,298 | $0.00 | |
| 1126F | 0% | 3,617 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 95 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 375 | $0.00 |
| 90620 | 0% | 239 | $0.00 | |
| 96161 | 0% | 217 | $0.00 | |
| 85018 | 0% | 1,077 | $0.00 | |
| 0072A | 0% | 278 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 11,940 | $0.00 |
| 36416 | 0% | 398 | $0.00 | |
| 90619 | 0% | 298 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 118 | $0.00 |
| 96156 | 0% | 510 | $0.00 | |
| 87807 | 0% | 280 | $0.00 | |
| 1036F | 0% | 3,210 | $0.00 | |
| 0111A | 0% | 33 | $0.00 | |
| 90697 | 0% | 102 | $0.00 | |
| 90480 | 0% | 112 | $0.00 | |
| 1125F | 0% | 552 | $0.00 | |
| 90698 | 0% | 104 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 1,110 | $0.00 |
| 0154A | 0% | 25 | $0.00 | |
| 96150 | 0% | 660 | $0.00 | |
| 0112A | 0% | 12 | $0.00 | |
| 90688 | 0% | 251 | $0.00 | |
| 87428 | 0% | 617 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 27 | $0.00 |
| 96151 | 0% | 12 | $0.00 | |
| 82962 | 0% | 14 | $0.00 | |
| 86580 | 0% | 48 | $0.00 | |
| 90723 | 0% | 201 | $0.00 | |
| 90696 | 0% | 111 | $0.00 | |
| 0081A | 0% | 28 | $0.00 | |
| 0074A | 0% | 90 | $0.00 | |
| 90716 | 0% | 65 | $0.00 | |
| 91307 | 0% | 16 | $0.00 | |
| 91301 | 0% | 150 | $0.00 | |
| 82150 | 0% | 35 | $0.00 | |
| 82040 | 0% | 35 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 21 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 86 | $0.00 |
| 84075 | 0% | 35 | $0.00 | |
| 90656 | 0% | 320 | $0.00 | |
| 1111F | 0% | 32 | $0.00 | |
| 3079F | 0% | 13 | $0.00 | |
| 96380 | 0% | 15 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 13 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 12 | $0.00 |
| 3078F | 0% | 3,648 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 3,694 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 2,282 | $0.00 |
| D0190 | 0% | 2,193 | $0.00 | |
| 96167 | 0% | 718 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 2,285 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 2,728 | $0.00 |
| D9996 | 0% | 2,276 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 3,530 | $0.00 |
| 90633 | 0% | 626 | $0.00 | |
| 90670 | 0% | 586 | $0.00 | |
| 84155 | 0% | 35 | $0.00 | |
| 90671 | 0% | 658 | $0.00 | |
| 90710 | 0% | 104 | $0.00 | |
| 90681 | 0% | 130 | $0.00 | |
| 90715 | 0% | 179 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 164 | $0.00 |
| 81025 | 0% | 77 | $0.00 | |
| 1159F | 0% | 4,585 | $0.00 | |
| 83655 | 0% | 797 | $0.00 | |
| 90707 | 0% | 38 | $0.00 | |
| 99177 | 0% | 492 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 82 | $0.00 |
| 81002 | 0% | 585 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 108 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 162 | $0.00 |
| 90734 | 0% | 186 | $0.00 | |
| 82247 | 0% | 35 | $0.00 | |
| 90648 | 0% | 395 | $0.00 | |
| 97803 | 0% | 679 | $0.00 | |
| 91312 | 0% | 50 | $0.00 | |
| 81003 | 0% | 478 | $0.00 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 0% | 32 | $0.00 |
| 82977 | 0% | 34 | $0.00 | |
| 0004A | 0% | 99 | $0.00 | |
| 84460 | 0% | 36 | $0.00 | |
| 0054A | 0% | 119 | $0.00 | |
| 90700 | 0% | 57 | $0.00 | |
| 84450 | 0% | 36 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 35 | $0.00 |
| 91300 | 0% | 855 | $0.00 | |
| 0124A | 0% | 126 | $0.00 | |
| 90685 | 0% | 56 | $0.00 | |
| 99188 | 0% | 38 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 15 | $0.00 |
| 90687 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMELK, JONATHAN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Chiricahua Community Health Centers, INC | Bisbee, AZ | $24.77M |
| Chiricahua Community Health Centers, INC | Sierra Vista, AZ | $19.00M |
| Chiricahua Community Health Centers, INC | Sierra Vista, AZ | $15.06M |
| Chiricahua Community Health Centers, INC | Douglas, AZ | $14.05M |
| Chiricahua Community Health Centers, INC | Benson, AZ | $9.26M |
| Chiricahua Community Health Centers, INC | Douglas, AZ | $8.52M |
| Chiricahua Community Health Centers, INC | Douglas, AZ | $3.82M |
| Chiricahua Community Health Centers, INC | Elfrida, AZ | $1.34M |
| Chiricahua Community Health Centers, INC | Bisbee, AZ | $597K |
| Chiricahua Community Health Centers, INC | Sierra Vista, AZ | $511K |
| Chiricahua Community Health Centers, INC. | Sierra Vista, AZ | $191K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.